The Molecular Pathogenesis of Health Disparities in Inf*
The Molecular Pathogenesis of Health Disparities in Inf*
批准号:
6654496
负责人:
EMMET HIRSCH
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-24 至 2006-07-31
关键词:
DNA Escherichia coli RNA bacteria infection mechanism decidua disease /disorder model disease /disorder proneness /risk embryo /fetus membrane epidemiology female gene expression genetic susceptibility human tissue induced labor infection laboratory mouse microarray technology molecular biology information system myometrium ovary pathologic process placenta premature labor racial /ethnic difference tissue /cell culture
中文摘要
描述(由申请人提供):
早产的发生率已经有很好的记录,但相对影响
与环境和行为因素相比,
不知道。本提案的目的是检验以下假设:
差异基因表达导致了感染相关的
早产第二个目标是建立两个大型和新颖的
资源研究早产:(1)候选人的关键数据库
基因,和(2)人基因表达组织库。我们建议
阐明早产的病理生理学需要执行
分析了分娩所需的母胎相互作用
基因组规模出于实践和伦理的原因,这种类型的初步研究
在人类中的应用将受到严重限制。因此,在第一阶段,
项目中,我们将使用一个经过验证的,严格控制的小鼠模型,
感染引起早产产生一个全面的基因目录
在多种组织中随时间的表达。早产妊娠小鼠将
随机分配至模拟临床状况之一的治疗组:A.
分娩感染; B.感染无分娩; C.分娩无感染;
和D.无感染/无分娩。然后从子宫肌层收集RNA,
卵巢、蜕膜、胎盘和胎膜,
时间序列,成千上万的基因的相对表达将是
使用DNA微阵列分析这些样本。相似性度量和
聚类算法将被用来分类个别基因的时间
表达模式一种新的减法策略将使我们能够
将感染诱导的特异性活性转录物与那些
对感染或分娩都很重要将得出关于
通过作图,涉及在微阵列中未被明确表示的基因
进入已知的功能通路。分析的最终结果将是
具有潜在关键作用的候选基因的“短名单”,
感染导致的分娩在项目的第二阶段,我们分析了人类
组织(子宫肌层、胎盘、绒毛膜、羊膜、蜕膜、滋养细胞和血液)
从约1360例足月和早产患者中收集
在一项与种族匹配的横断面病例对照研究中,表达
在这些组织中的分析将针对人类同源物,
在小鼠中鉴定的候选关键基因的丰富列表。
感染与未感染早产的基因表达差异
胎膜早破,以及不同种族群体之间,将是
表征了一种被称为支持向量机的计算工具将被
用于生成预测早产的排序列表,
考虑到历史、临床和实验室变量。本工具将
确定最有可能形成遗传基础的基因子集
早产,并可提供诊断分子谱分析仪器,
预测早产本研究中生成的大型数据库将
对任何对分娩感兴趣的研究人员都是有价值的,
可以在互联网上找到。
英文摘要
DESCRIPTION (provided by applicant): Racial and ethnic disparities in the
incidence of preterm labor have been well documented, but the relative impact
of genetic predisposition, as compared to environmental and behavioral factors
is not known. The objective of this proposal is to test the hypothesis that
differential gene expression contributes to disparity in infection-associated
preterm labor. A second objective is the creation of two large and novel
resources for studying preterm labor: (1) a database of candidate critical
genes, and, (2) a human gene expression tissue bank. We suggest that
elucidating the pathophysiology of preterm labor requires the power to perform
analyses of the fetomaternal interactions required for parturition on a
genomic scale. For practical and ethical reasons, a primary study of this type
in humans would be severely limited. Therefore, in the first phase of this
project, we will use a validated, tightly controlled murine model of
infection-induced preterm labor to generate a comprehensive catalogue of gene
expression over time in multiple tissues. Preterm pregnant mice will be
randomized to treatment groups modeling one of clinical conditions: A.
infection with labor; B. infection without labor; C. labor without infection;
and D. no infection/no labor. RNA will then be collected from myometrium,
ovaries, decidua, placentas and fetal membranes from each of the groups in a
time series, and the relative expression of thousands of genes will be
analyzed in these samples using DNA microarrays. A similarity metric and a
clustering algorithm will be used to categorize individual genes by temporal
expression patterns. A novel subtractive strategy will allow us to
differentiate transcripts active specifically in infection-induced from those
important for infection or labor alone. Inferences will be drawn regarding the
involvement of genes not physic represented in the micro arrays by mapping
into known functional pathways. The final result of this analysis will be a
"short list" of candidate genes with potentially critical roles in
infection-induced labor. In the second phase of the project, we analyze human
tissues (myometrium, placenta, chorion, amnion, decidua, amniocytes and blood)
collected from approximately 1360 patients presenting in term and preterm
labor in a cross-sectional case-control study matching for race. Expression
analysis in these tissues will be targeted to the human homologues of the
enriched list of candidate critical genes identified in the mouse.
Differential gene expression in pre term labor with or without infection and
premature rupture membranes, as well as among different racial groups, will be
characterized. A computational tool known as a support vector machine will be
used to generate a rank order list predictive of preterm delivery, taking
into account historical, clinical and laboratory variables. This tool will
identify the subset(s) of genes most likely to form the genetic basis of
preterm labor, and may provide a diagnostic molecular profiling instrument for
predicting preterm delivery. The large databases generated in this study will
be valuable to any researcher interested in parturition and will be made
accessible on the Internet.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
-
批准号:10403521
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2019
-
负责人:EMMET HIRSCH
-
依托单位:
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
-
批准号:9913576
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2019
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:8113517
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2010
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:8306264
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:7528461
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:7900346
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:7693765
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:8097306
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6776475
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6929305
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6526935
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
PATHOGENESIS OF HEALTH DISPARITIES IN PRETERM BIRTH
-
批准号:6437197
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2330256
-
项目类别:
-
资助金额:$9.68万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2057177
-
项目类别:
-
资助金额:$9.52万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2057178
-
项目类别:
-
资助金额:$9.59万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:3085492
-
项目类别:
-
资助金额:$8.29万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2057176
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: